cardiac selective mineralocorticoid receptor inhibitors (oral, cardiac failure/cardiac fibrosis)

Cardiac Fibrosis(Hepion)

Allogeneic processed thymus tissue(Rethymic)

Human Placenta Tissue Hydrolysate

Rx

siRNA therapies (cardiac disorders)

cardiac precursor cell stimulators

BDM-K

siRNA targeting tissue factor(siRNAsense/Biomedical Innovation/Biotechnology Centre of Oslo)

NLRP3 inflammasome inhibitor (cardiac inflammation)

GPR37L1 modulators (hypertension/cardiac hypertrophy)